Invenomic Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dropbox
DBX
|
+$19.2M |
| 2 |
POSH
Poshmark, Inc. Class A Common Stock
POSH
|
+$18.8M |
| 3 |
ROVR
Rover Group, Inc. Class A Common Stock
ROVR
|
+$17.2M |
| 4 |
Liberty Latin America Class C
LILAK
|
+$16M |
| 5 |
CVSA
Covista Inc
CVSA
|
+$15.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GTS
Triple-S Management Corporation
GTS
|
+$8.68M |
| 2 |
McKesson
MCK
|
+$7.88M |
| 3 |
FirstEnergy
FE
|
+$6.16M |
| 4 |
Halliburton
HAL
|
+$4.98M |
| 5 |
BDSI
BioDelivery Sciences International, Inc.
BDSI
|
+$3.69M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.4% |
| 2 | Technology | 15.87% |
| 3 | Consumer Staples | 7.14% |
| 4 | Communication Services | 7.12% |
| 5 | Healthcare | 6.64% |
Similar funds
Invenomic Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Invenomic Capital Management held 195 positions worth $937M, up 100% from $468M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Invenomic Capital Management deployed $599M of net new capital in Q1 2022, opening 53 new positions and adding to 82 existing holdings. Its largest new stake was Rover Group, Inc. Class A Common Stock: 2,877,600 shares worth $16.6M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 12% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was Stride, an estimated $3.67M trimmed.
- Invenomic Capital Management's largest Q1 2022 buy was Rover Group, Inc. Class A Common Stock: 2,877,600 shares worth $16.6M.
- Invenomic Capital Management added most to Dropbox in Q1 2022, an estimated $19.2M increase.
- Invenomic Capital Management's biggest Q1 2022 reduction was Stride, cutting an estimated $3.67M.
- Invenomic Capital Management fully exited Triple-S Management Corporation in Q1 2022, selling an estimated $8.68M.
- Invenomic Capital Management's ten largest holdings make up 35% of its $937M portfolio in Q1 2022.
- Invenomic Capital Management opened 53 new positions and closed 41 in Q1 2022.
- Invenomic Capital Management's portfolio value rose 100% quarter-over-quarter to $937M.
Based on Invenomic Capital Management's 13F filing for Q1 2022, filed 16 May 2022.